Barry Biffle plans share sale in ULCC (NASDAQ: ULCC)

Rhea-AI Filing Summary

ULCC shareholder Barry Biffle has filed notice to sell 94,960 common shares. The planned sale is through UBS Financial Services on NASDAQ, with an aggregate market value of $526,695.64 based on the filing. The notice states 228,950,914 common shares were outstanding as of the filing, providing context for the relative size of this planned transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	94960	526695.64	228950914	02/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2025	Exercise of Stock Options	Issuer			94960	01/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Barry Biffle 4545 AIRPORT WAY DENVER CO 80239	Common	12/04/2025	55187	277899.66
Barry Biffle 4545 AIRPORT WAY DENVER CO 80239	Common	12/05/2025	44813	226224.99
Barry Biffle 4545 AIRPORT WAY DENVER CO 80239	Common	12/08/2025	100000	554290.00
Barry Biffle 4545 AIRPORT WAY DENVER CO 80239	Common	12/10/2025	17373	104422.15
Barry Biffle 4545 AIRPORT WAY DENVER CO 80239	Common	12/11/2025	82627	477674.95
Barry Biffle 4545 AIRPORT WAY DENVER CO 80239	Common	01/22/2026	5040	27770.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ULCC shares does Barry Biffle plan to sell under this notice?

Barry Biffle plans to sell 94,960 ULCC common shares under this notice. The planned transaction, handled by UBS Financial Services on NASDAQ, has an aggregate market value of $526,695.64 according to the filing’s securities information table.

When were the ULCC shares to be sold by Barry Biffle acquired?

The 94,960 ULCC common shares were acquired on January 15, 2025 through an exercise of stock options. The filing notes that the issuer was the counterparty and the purchase price was paid in cash on the same date.

What prior ULCC share sales has Barry Biffle reported in the last three months?

The filing lists several prior ULCC common share sales by Barry Biffle in December 2025 and January 2026, including individual transactions of 100,000 shares for $554,290.00 and 82,627 shares for $477,674.95, among other smaller trades and proceeds.

On which exchange are the ULCC shares in this planned sale to be traded?

The planned sale of 94,960 ULCC common shares is indicated for trading on NASDAQ. The filing identifies NASDAQ as the securities exchange and lists UBS Financial Services, Inc. as the broker handling the transaction.

How many ULCC shares were outstanding in relation to Barry Biffle’s planned sale?

The filing reports 228,950,914 ULCC common shares outstanding as context for the planned sale. This baseline outstanding share figure is presented alongside the 94,960 shares to be sold and the related aggregate market value of $526,695.64.

What representation does Barry Biffle make about ULCC information in this notice?

By signing the notice, the person for whose account the ULCC securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required in the form’s signature section.